Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

Klein, 1969

A. CARLSSON and M. LINDQVIST, Acta Pharmacol. Toxicol. 20 140–144.

Kebabian, 1972, 69, 2145

Snyder, 1975, Psychopharmacol. Commun., 1, 663

Snyder, 1974, Science, 184, 1243, 10.1126/science.184.4143.1243

Anden, 1972, J. Pharm. Pharmacol., 24, 177, 10.1111/j.2042-7158.1972.tb08961.x

Scatton, 1977, Europ. J. Pharmacol., 46, 363, 10.1016/0014-2999(77)90230-8

Asper, 1973, Europ. J. Pharmacol., 22, 287, 10.1016/0014-2999(73)90028-9

Bowers, 1974, J. Pharm. Pharmacol., 26, 743, 10.1111/j.2042-7158.1974.tb09365.x

Konig, 1970

Bunney, 1973, J. Pharm. Exp. Ther., 185, 560

P. G. GUYENET and G. K. AGHAJANIAN, Brain Res., in press.

Tasaki, 1968, Physiol. Behav., 3, 1009, 10.1016/0031-9384(68)90193-5

Aghajanian, 1970, J. Pharmacol. Exp. Ther., 171, 178

Thomas, 1965, Nature (London), 206, 211, 10.1038/206211b0

Bunney, 1976, Brain Res., 117, 423, 10.1016/0006-8993(76)90751-4

Grofova, 1975, Brain Res., 91, 286, 10.1016/0006-8993(75)90550-8

Bunney, 1976, The Basal Ganglia, 249

B. S. BUNNEY and G. K. AGHAJANIAN, Naunyn-Schmiedeberg's Arch. Pharmacol. in press.

Aghajanian, 1977, Naunyn-Schmiedeberg's Arch. Pharmacol., 297, 1, 10.1007/BF00508803

Anden, 1967, J. Pharm. Pharmacol., 19, 627, 10.1111/j.2042-7158.1967.tb09604.x

Ernst, 1967, Psychopharmacologia, 10, 316, 10.1007/BF00403900

Schwarcz, 1977, Brain Res., 127, 235, 10.1016/0006-8993(77)90538-8

Ohman, 1977, Naunyn-Schmiedeberg's Arch. Pharmacol., 299, 104, 10.1007/BF00498552

Aghajanian, 1974, 444

Kandell, 1961, J. Neurophysiol., 24, 243, 10.1152/jn.1961.24.3.243

Shepherd, 1963, J. Physiol., 168, 101, 10.1113/jphysiol.1963.sp007180

Rinvik, 1970, Exp. Brain. Res., 11, 229, 10.1007/BF01474384

Gulley, 1971, Tissue and Cell, 3, 675, 10.1016/S0040-8166(71)80013-7

Groves, 1975, Science, 190, 522, 10.1126/science.242074

Cheramy, 1977, J. Pharmacol. Exp. Ther., 203, 283

Scheel-Kruger, 1977, Neurosci. Lett., 4, 351, 10.1016/0304-3940(77)90183-5

Kanazawa, 1977, Brain Res., 119, 447, 10.1016/0006-8993(77)90323-7

Hong, 1977, Brain Res., 122, 541, 10.1016/0006-8993(77)90464-4

Post, 1975, Science, 190, 488, 10.1126/science.1166321

Gerlach, 1975, Psychopharmacologia (Berl.), 40, 341, 10.1007/BF00421473

Carlsson, 1963, Acta Pharmacol. Toxicol., 20, 140, 10.1111/j.1600-0773.1963.tb01730.x

Nyback, 1968, Europ. J. Pharmacol., 4, 395, 10.1016/0014-2999(68)90025-3

Anden, 1964, Life Sci., 3, 149, 10.1016/0024-3205(64)90196-1

Gallager, 1978, Nature, 273, 309, 10.1038/273309a0

Hornykiewicz, 1975, Vol. 9, 155

Meltzer, 1976, Schizophrenia Bull., 2, 19, 10.1093/schbul/2.1.19

Kehr, 1972, J. Pharm. Pharmacol., 24, 744, 10.1111/j.2042-7158.1972.tb09104.x

Roth, 1975, Antipsychotic Drugs, Pharmacodynamics and Pharmacokinetics, 133

Klawans, 1973, Amer. J. Psychiat., 130, 82, 10.1176/ajp.130.1.82

Nieoullon, 1977, Nature, 269, 340, 10.1038/269340a0

Yarbrough, 1975, Europ. J. Pharmacol., 31, 367, 10.1016/0014-2999(75)90062-X